Investigator-initiated studies
The influence of small vessel cerebrovascular lesions on cognition and tau in Parkinson’s disease [National Neuroscience Institute, Singapore; 2013 – 2014]
The frequency of anti-NMDA receptor and anti-VGKC encephalitides in patients presenting with first-episode psychosis [National Neuroscience Institute, Singapore; 2013 – 2014] - Main protocol administrator
Multimodal connectome analysis for differentiating subtypes within early-stage dementia and mild cognitive impairment [National Neuroscience Institute, Singapore; 2013 – 2016]
PAWS - Parkinson's and Alzheimer's disease and impact of White matter disease Study [National Neuroscience Institute, Singapore; 2014 – present] - Data collection and analysis – cognitive and neuroimaging (2014 – 2018)
Correlation of cognition profile and cerebral ischemia among stroke patients attending National Neuroscience Institute outpatient clinics – The Singapore Ischemic Stroke Cognitive Outcomes (SISCO) study [National Neuroscience Institute, Singapore; 2013 – present]
Main protocol administrator (2013 – 2018)
Data collection and analysis – neuroimaging visual rating (2013 – 2018)
Collaborator (2018 – present)
Study to elucidate the influence of neuroinflammation including “Damage Associated Molecular Patterns (DAMPs)” in the sundrome of Alzheimer’s disease with small vessel cerebrovascular disease (AD+svCVD) [National Neuroscience Institute, Singapore; 2014 – 2018]
Singapore YouNg dementia Cohort (SYNC) study: Clinical, pathophysiological, and economic cost characterization [National Neuroscience Institute, Singapore; 2015 – present]
Data collection and analysis – cognitive and neuroimaging (2015 – 2018)
Neuropsychological reports and case presentations (2015 – 2018)
Collaborator (2018 – present)
Subjective cognitive decline and objective cognitive deficits in Singaporean community elderly [National Neuroscience Institute, Singapore; 2015 – present]
STROKOG international consortium of longitudinal studies of cognitive disorders following stroke [University of New South Wales; 2016 – present]
Study site coordinator (National Neuroscience Institute, Singapore; 2016 – 2018)
Collaborator (2018 – present)
Clinical effects and pathophysiology of vitamin deficiency in neurocognitive disorders: The Vitamins, brain Imaging, and Cognition - Singapore Study (VICSS) [National Neuroscience Institute, Singapore; 2017 – present]
Clinical trials
Double-blind, placebo-controlled, randomized, parallel-group, 12-month safety and efficacy trial of leuco-methylthioninium bis(hydromethanesulfonate) in subjects with behavioral variant frontotemporal dementia (bvFTD) [TauRx Therapeutics]
Randomized, double-bling, placebo controlled, parallel-group, 12-month trial of leuco-methylthioninium bis(hydromethanesulfonate) in subjects with mild to moderate Alzheimer's disease study: Phase 3 [TauRx Therapeutics]
An open-label extension study of the effects of leuco-methylthioninium bis(hydromethanesulfonate) in subjects with Alzheimer's disease or behavioural variant frontotemporal dementia [TauRx Therapeutics]
Randomized, double-blind, parallel-group, placebo-controlled study of Lu AE58054 in patients with mild-moderate Alzheimers disease treated with an acetylcholinesterase inhibitor; Study 3 [Lundbeck]
Open-label trial of rivastigmine patch in subjects with mild to moderate stage Alzheimer's disease having coexisting small-vessel cerebrovascular disease [Novartis]